藥物濫用檢測市場規模、佔有率和成長分析(按產品、檢體類型、應用、最終用戶和地區分類)—產業預測(2026-2033 年)
市場調查報告書
商品編碼
1915962

藥物濫用檢測市場規模、佔有率和成長分析(按產品、檢體類型、應用、最終用戶和地區分類)—產業預測(2026-2033 年)

Drugs Of Abuse Testing Market Size, Share, and Growth Analysis, By Product (Consumables, Equipment), By Sample Type (Saliva, Urine), By Application, By End User, By Region - Industry Forecast 2026-2033.

出版日期: | 出版商: SkyQuest | 英文 181 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球藥物濫用檢測市場規模預計在 2024 年達到 68 億美元,從 2025 年的 69 億美元成長到 2033 年的 77.8 億美元,在預測期(2026-2033 年)內複合年成長率為 1.5%。

全球藥物濫用檢測市場預計將迎來顯著成長,這主要得益於企業健康檢查的日益普及和藥物濫用發生率的上升。人們對藥物濫用障礙的認知不斷提高以及監管的日益嚴格,正在推動市場創新。藥物相關死亡人數的增加凸顯了對可靠檢測方法的迫切需求,從而推動了公共和醫療保健領域對先進解決方案的需求。關鍵趨勢包括向就地檢驗和快速檢測的轉變,這些方法能夠提供更高的準確性和速度,尤其是在路邊和職場環境中。穿戴式裝置和非侵入性檢測方法(例如唾液和汗液分析)等技術進步也正在廣泛應用。然而,開發中國家意識不足、檢測設備高成本以及嚴格的監管等挑戰可能會減緩市場擴張。

全球藥物濫用檢測市場促進因素

技術創新推動了高精度檢測設備的研發,顯著促進了全球藥物濫用檢測市場的成長。隨著生活水準的提高,成年人對藥物濫用檢測的需求日益成長。政府機構和私人企業積極倡導預防措施,以遏止成年人藥物濫用,進一步推動了這一趨勢。先進技術與社會壓力之間的協同作用,正在鞏固藥物檢測解決方案的基礎,並推動市場動態。

限制全球藥物濫用檢測市場的因素

成本和可負擔性是全球藥物濫用檢測市場滲透的重大挑戰。許多中小企業和醫療機構發現,全面的檢測項目費用高昂,難以負擔,限制了產業發展機會。此外,市場也擔憂檢測結果被篡改和規避,因為個人常常會採取一些會降低檢測準確性的方法(例如使用合成尿液或各種掩蔽劑來規避檢測)。這些問題不僅會降低檢測程序的可靠性,還會阻礙整個產業的發展,從而阻礙其更廣泛的應用和實施。

全球藥物濫用檢測市場趨勢

全球藥物濫用檢測市場正經歷著向非侵入性檢測技術的顯著轉變,這主要得益於人們對更便利、更安全、更非侵入性採樣方法的需求。汗液、毛髮和唾液等檢體採集方法因其操作簡單、污染風險低、隱私顧慮少等優點,正日益受到青睞,遠勝於傳統的血液和尿液檢查等方法。這些創新技術不僅延長了檢測窗口期,尤其有利於檢測慢性藥物濫用,而且已被廣泛應用於路邊檢測、康復機構和職場藥物檢測等各種場景,代表著該行業的變革性趨勢。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 一手和二手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 用例
  • 顧客購買行為分析

全球藥物濫用檢測市場規模(按產品和複合年成長率分類)(2026-2033 年)

  • 消耗品
  • 裝置
  • 快速檢測裝置
  • 服務

全球藥物濫用檢測市場規模(按檢體類型和複合年成長率分類)(2026-2033 年)

  • 唾液
  • 尿
  • 頭髮
  • 吐氣

全球藥物濫用檢測市場規模(按應用領域及複合年成長率分類)(2026-2033 年)

  • 篩檢
  • 疼痛管理監測
  • 法醫學/法律資訊
  • 就業藥物檢測
  • 體育比賽測試

全球藥物濫用檢測市場規模(依最終用戶分類)及複合年成長率(2026-2033 年)

  • 醫院
  • 法醫學實驗室
  • 診斷中心
  • 專科診所

全球藥物濫用檢測市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • GCC
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)

主要企業簡介

  • Quest Diagnostics Incorporated
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Quidel Corporation
  • Express Diagnostics International Inc.
  • Blue Origin
  • Thermo Fisher Scientific, Inc
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Laboratory Corporation of America Holdings
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions
  • Merck KGaA

結論與建議

簡介目錄
Product Code: SQMIG35J2146

Global Drugs Of Abuse Testing Market size was valued at USD 6.8 Billion in 2024 and is poised to grow from USD 6.9 Billion in 2025 to USD 7.78 Billion by 2033, growing at a CAGR of 1.5% during the forecast period (2026-2033).

The global drugs of abuse testing market is poised for significant growth, driven by an increasing trend in employment medical screenings and the rising incidence of substance use. Growing awareness of substance use disorders and stringent regulations are propelling market innovation. The urgent need for reliable testing methods, highlighted by rising drug-related fatalities, spurs demand for advanced solutions in public safety and healthcare. Key trends include a shift towards point-of-care and rapid testing, enhancing accuracy and timeliness, particularly in roadside and workplace scenarios. Technological advancements, like wearable devices and non-invasive testing methods, such as saliva and sweat analysis, are gaining traction. Nonetheless, challenges such as limited awareness in developing countries, high costs of testing devices, and stringent regulations may slow market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drugs Of Abuse Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drugs Of Abuse Testing Market Segments Analysis

Global Drugs Of Abuse Testing Market is segmented by Product, Sample Type, Application, End User and region. Based on Product, the market is segmented into Consumables, Equipment, Rapid Testing Devices and Services. Based on Sample Type, the market is segmented into Saliva, Urine, Hair, Breath, Blood and Sweat. Based on Application, the market is segmented into Medical Screening, Monitoring Pain Management, Forensic & Legal Information, Employment Drug Testing and Sports & Athletics Testing. Based on End User, the market is segmented into Hospital, Forensic Labs, Diagnostic Centres and Speciality Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drugs Of Abuse Testing Market

Technological advancements have led to the creation of highly precise and accurate testing instruments, significantly driving the growth of the Global Drugs of Abuse Testing market. As living standards continue to rise, there is an increasing necessity for adults to undergo drug abuse testing. This trend is further supported by initiatives from both government agencies and private enterprises that advocate for drug of abuse testing as a proactive measure to combat drug misuse among adults. The combined influence of advanced technology and societal pressures is fostering a more robust landscape for drug testing solutions, thereby enhancing market dynamics.

Restraints in the Global Drugs Of Abuse Testing Market

Cost and affordability present significant challenges for the penetration of the global drugs of abuse testing market. Many small companies and healthcare providers find comprehensive testing programs prohibitively expensive, which limits the industry's growth opportunities. Additionally, the market faces concerns related to adulteration and evasion tactics, as individuals often resort to strategies that compromise the accuracy of screening methods, such as using synthetic urine or various masking agents to pass tests. These issues not only undermine the reliability of testing procedures but also hinder the overall advancement of the sector, creating barriers for wider adoption and implementation.

Market Trends of the Global Drugs Of Abuse Testing Market

The Global Drugs of Abuse Testing market is witnessing a significant shift towards non-invasive testing techniques, driven by the demand for simpler, safer, and less intrusive sampling methods. Collection of samples such as sweat, hair, and saliva is gaining popularity due to their ease of use, reduced risk of contamination, and minimal privacy concerns compared to traditional methods like blood and urine tests. These innovative techniques not only extend detection windows, particularly beneficial for chronic use, but are also being increasingly adopted in diverse applications such as roadside testing, rehabilitation centers, and workplace drug testing, indicating a transformative trend in the industry.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Drugs Of Abuse Testing Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Consumables
  • Equipment
  • Rapid Testing Devices
  • Services

Global Drugs Of Abuse Testing Market Size by Sample Type & CAGR (2026-2033)

  • Market Overview
  • Saliva
  • Urine
  • Hair
  • Breath
  • Blood
  • Sweat

Global Drugs Of Abuse Testing Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Medical Screening
  • Monitoring Pain Management
  • Forensic & Legal Information
  • Employment Drug Testing
  • Sports & Athletics Testing

Global Drugs Of Abuse Testing Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospital
  • Forensic Labs
  • Diagnostic Centres
  • Speciality Clinics

Global Drugs Of Abuse Testing Market Size & CAGR (2026-2033)

  • North America (Product, Sample Type, Application, End User)
    • US
    • Canada
  • Europe (Product, Sample Type, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Sample Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Sample Type, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Sample Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025

Key Company Profiles

  • Quest Diagnostics Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quidel Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Express Diagnostics International Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Blue Origin
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthcare GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratory Corporation of America Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clinical Reference Laboratory, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cordant Health Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations